Weifeng Tang

3.5k total citations
169 papers, 2.5k citations indexed

About

Weifeng Tang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Weifeng Tang has authored 169 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 44 papers in Cancer Research and 36 papers in Immunology. Recurrent topics in Weifeng Tang's work include RNA modifications and cancer (27 papers), Cancer-related molecular mechanisms research (21 papers) and Esophageal Cancer Research and Treatment (16 papers). Weifeng Tang is often cited by papers focused on RNA modifications and cancer (27 papers), Cancer-related molecular mechanisms research (21 papers) and Esophageal Cancer Research and Treatment (16 papers). Weifeng Tang collaborates with scholars based in China, United States and United Kingdom. Weifeng Tang's co-authors include Haiyong Gu, Hao Qiu, Yafeng Wang, Jun Yin, Shuchen Chen, Jingcheng Dong, Ying Wei, Jun Zhang, Guowen Ding and Yijun Shi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Weifeng Tang

168 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Tang China 26 1.0k 581 493 435 399 169 2.5k
Yon Ko Germany 31 1.2k 1.2× 389 0.7× 656 1.3× 385 0.9× 199 0.5× 69 3.1k
Lijian Shao China 27 1.7k 1.7× 368 0.6× 476 1.0× 548 1.3× 316 0.8× 64 3.6k
Shakil Ahmad United Kingdom 28 1.3k 1.3× 341 0.6× 220 0.4× 1.0k 2.4× 276 0.7× 86 4.1k
Carine Chavey France 20 1.2k 1.2× 516 0.9× 759 1.5× 415 1.0× 104 0.3× 29 2.7k
Hisashi Masuyama Japan 31 689 0.7× 182 0.3× 558 1.1× 342 0.8× 134 0.3× 164 3.1k
Lijie Zhen United States 17 1.9k 1.8× 462 0.8× 304 0.6× 545 1.3× 1.4k 3.5× 21 3.6k
Yingyi Zhang China 33 2.0k 2.0× 1.2k 2.0× 301 0.6× 357 0.8× 708 1.8× 104 4.0k
Youichiro Wada Japan 31 1.6k 1.6× 704 1.2× 361 0.7× 637 1.5× 256 0.6× 80 3.2k
Yuji Hiramatsu Japan 32 618 0.6× 234 0.4× 608 1.2× 254 0.6× 136 0.3× 136 3.2k
Rujun Gong United States 38 1.6k 1.6× 293 0.5× 196 0.4× 439 1.0× 432 1.1× 102 3.8k

Countries citing papers authored by Weifeng Tang

Since Specialization
Citations

This map shows the geographic impact of Weifeng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Tang more than expected).

Fields of papers citing papers by Weifeng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Tang. The network helps show where Weifeng Tang may publish in the future.

Co-authorship network of co-authors of Weifeng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Tang. A scholar is included among the top collaborators of Weifeng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Tang. Weifeng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Weifeng, et al.. (2024). Association of leptin receptor polymorphisms with susceptibility of non‐small cell lung cancer: Evidence from 2249 subjects. Cancer Medicine. 13(8). e7178–e7178. 2 indexed citations
2.
3.
Ouyang, Boshu, Na Wang, Weifeng Tang, et al.. (2023). Albumin-based formononetin nanomedicines for lung injury and fibrosis therapy via blocking macrophage pyroptosis. Materials Today Bio. 20. 100643–100643. 24 indexed citations
4.
Huo, Xiaona, et al.. (2023). Dietary and maternal sociodemographic determinants of perfluoroalkyl and polyfluoroalkyl substance levels in pregnant women. Chemosphere. 332. 138863–138863. 14 indexed citations
5.
Tang, Weifeng, et al.. (2023). The crosslinks between ferroptosis and autophagy in asthma. Frontiers in Immunology. 14. 1140791–1140791. 19 indexed citations
6.
Yang, Tianbao, et al.. (2023). Application of Intraoperative Neuromonitoring (IONM) of the Recurrent Laryngeal Nerve during Esophagectomy: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12(2). 565–565. 5 indexed citations
7.
Su, Feng, Yong Fang, Tian Jiang, et al.. (2022). The Single Nucleotide Polymorphisms of AP1S1 are Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Population. SHILAP Revista de lepidopterología. 4 indexed citations
8.
Li, Fangfang, Weifeng Tang, & Qiufei Xie. (2022). The viability of cell that encapsulated in calcium alginate hydrogel beads. Science and Engineering of Composite Materials. 29(1). 473–480. 3 indexed citations
9.
Huang, Xi, Hang Yu, Cong Xie, et al.. (2022). Louki Zupa decoction attenuates the airway inflammation in acute asthma mice induced by ovalbumin through IL-33/ST2-NF-κB/GSK3β/mTOR signalling pathway. Pharmaceutical Biology. 60(1). 1520–1532. 10 indexed citations
10.
Cui, Jie, Fangzhou Teng, La Yi, et al.. (2021). RNA-Seq Expression Analysis of Chronic Asthmatic Mice with Bu-Shen-Yi-Qi Formula Treatment and Prediction of Regulated Gene Targets of Anti-Airway Remodeling. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 4 indexed citations
11.
Zhu, Xueyi, Jie Cui, La Yi, et al.. (2020). The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk. Mediators of Inflammation. 2020. 1–14. 40 indexed citations
12.
13.
14.
Zhou, Dong, Weifeng Tang, Yuji Zhang, & Han‐Xiang An. (2019). JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Qiu, Hao, et al.. (2019). Associations Between microRNA Polymorphisms and Development of Coronary Artery Disease: A Case–Control Study. DNA and Cell Biology. 39(1). 25–36. 13 indexed citations
16.
Liu, Jun, Weifeng Tang, Wanzun Lin, et al.. (2019). Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population. DNA and Cell Biology. 38(5). 443–448. 11 indexed citations
17.
Liu, Jun, Miao Liu, Jiling Wang, et al.. (2019). Comparison of Three Different Assays for the Detection of Tumor Antigen-Induced Lymphocyte Transformation In Vitro. DNA and Cell Biology. 38(11). 1402–1410. 1 indexed citations
18.
Zhang, Sheng, Zhan Chen, Yafeng Wang, et al.. (2018). Investigation of <em>LEP </em>and <em>LEPR </em>polymorphisms with the risk of hepatocellular carcinoma: a case&ndash;control study in Eastern Chinese Han population. OncoTargets and Therapy. Volume 11. 2083–2089. 13 indexed citations
19.
Wang, Yuhe, Michelle Kang, Hu Ding, et al.. (2017). The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population. SHILAP Revista de lepidopterología. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yon Ko Breakdown of academic impact, for papers by Lijian Shao Breakdown of academic impact, for papers by Shakil Ahmad Breakdown of academic impact, for papers by Carine Chavey Breakdown of academic impact, for papers by Hisashi Masuyama Breakdown of academic impact, for papers by Lijie Zhen Breakdown of academic impact, for papers by Yingyi Zhang Breakdown of academic impact, for papers by Youichiro Wada Breakdown of academic impact, for papers by Yuji Hiramatsu Breakdown of academic impact, for papers by Rujun Gong
Rankless by CCL
2026